News
Messenger RNA, or mRNA – a technology that can instruct cells to fight disease – has fueled breakthroughs from Covid vaccines ...
A new multi-omics AI model combines cfDNA and cfRNA to predict preterm birth risk with nearly 90% accuracy, offering ...
A new study presents GeneLLM, an AI-driven framework integrating cfDNA and cfRNA to improve preterm birth detection. Tested ...
4h
The Kenya Times on MSNUganda Inks Deal with U.S. Researchers to Combat Cancer
Uganda is collaborating with researchers from the United States to develop treatments for cancer and diabetes. Uganda’s ...
17h
Zacks Investment Research on MSNRNA Stock Moves More Than 30% in a Week: What's Driving This Rally?
Shares of Avidity Biosciences RNA have soared 36% in the past month, all thanks to a report issued by the Financial Times (FT ...
The candidates are sourced from Arnatar’s next-gen RNA discovery engine, dubbed DARGER for dual-functional antisense RNA for ...
Arnatar is developing ART4, an antisense oligonucleotide that ups the expression of its target protein to treat a rare ...
Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration ...
Certain types of biochemical processes can impair the immune system’s ability to recognize and kill cancer cells. Purdue ...
From Johns Hopkins University School of Medicine, Charlotte J. Sumner, M.D., presents an editorial on a study by Richard S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results